In order to provide the best software and product support for our customers, QIAGEN must periodically retire older versions of…

Our recent Variant Analysis update includes several key features, most notably, improved data export (now completed offline to improve performance)…

An estimated 300 million people worldwide live with some form of rare disease. In the US, a disease is considered…

Here at QIAGEN, we frequently fine-tune our solutions to better serve and support our customers in the international research and…

There are few meetings as important to the bioinformatics community as Intelligent Systems for Molecular Biology (ISMB), which is celebrating…

Accelerating the deployment of precision medicine capabilities How a leading academic hospital is analyzing complex clinical data and uncovering new…

It’s great to read about how our solutions are being used and the amazing work they support. We rounded up…

Research scientist Dr. Margarete Odenthal leads the translational molecular pathology group at University Hospital Cologne, putting new technologies through their…

Nearly 250 million people around the world are affected by rare diseases, which are typically genetic in nature. Their rarity…

As a provider of bioinformatics tools designed to provide insight and accelerate scientific analysis and interpretation, we love to read…

Our hereditary disease solution performs best in terms of clinical accuracy at the Critical Assessment of Genome Interpretation (CAGI) conference….

From IPA and Ingenuity® Variant Analysis™ to Biomedical Genomics Workbench, we’re honored to see that our products are on the…